FDA approves Pfizer vaccine magenta cap In children 6 months – less than 5 years, 3 injections, 3 micrograms each, indicates 80.3% protection against COVID-19.
On August 24, 2022, Dr. Paisan Dankhum, Secretary-General of the Food and Drug Administration (FDA) revealed that on August 23, 2022, the Sub-Committee considering registration of modern drug formulas for human vaccines. Prevention of Coronavirus Disease 2019 has resolved to approve the expansion of the indications of COMIRNATY VACCINE of Pfizer Co., Ltd. for children aged 6 months – less than 5 years, colored cap bottles. Red purple to prevent COVID-19
Previously, the company The immunization vaccine is approved for use in people 12 years of age and older, and has been extended for use in children 5-11 years of age for pediatric injections. The vaccination dose was reduced to 10 micrograms with two doses of intramuscular vaccination 21 days apart.
For children aged 6 months to less than 5 years, 0.2 ml (3 mcg) doses of the vaccine will be administered as 3 doses, where the 2nd dose is 3 weeks away from the 1st dose, and the 3rd dose is away from the 2nd dose for 8 weeks. can prevent the disease from COVID-19 by 80.3%